Recruiting Thrombocytopenia Studies in Iowa City
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it ...
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP). After an up to 2 weeks screening period, el...
About Thrombocytopenia Clinical Trials in Iowa City
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
There are currently 2 thrombocytopenia clinical trials recruiting participants in Iowa City, IOWA. These studies are seeking a combined 234 participants. Research is being sponsored by Takeda, argenx. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thrombocytopenia Clinical Trials in Iowa City — FAQ
Are there thrombocytopenia clinical trials in Iowa City?
Yes, there are 2 thrombocytopenia clinical trials currently recruiting in Iowa City, IOWA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Iowa City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.
Are clinical trials in Iowa City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.
What thrombocytopenia treatments are being tested?
The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.
Data updated March 2, 2026 from ClinicalTrials.gov